Genetic insights into lung squamous cell carcinoma: how TP53 and CSMD3 co-mutations shape prognosis and immune response.

Han D, Wu C, Wang D, Dong Y, Jin H

Open source

DOI
10.21037/tcr-2026-1534
Published
2026 Aug 31
Container
Translational cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-1534,
  title = {Genetic insights into lung squamous cell carcinoma: how TP53 and CSMD3 co-mutations shape prognosis and immune response.},
  author = {Han D and Wu C and Wang D and Dong Y and Jin H},
  year = {2026},
  journal = {Translational cancer research},
  doi = {10.21037/tcr-2026-1534},
  url = {https://doi.org/10.21037/tcr-2026-1534}
}

RIS

TY  - JOUR
TI  - Genetic insights into lung squamous cell carcinoma: how TP53 and CSMD3 co-mutations shape prognosis and immune response.
AU  - Han D
AU  - Wu C
AU  - Wang D
AU  - Dong Y
AU  - Jin H
PY  - 2026
JO  - Translational cancer research
DO  - 10.21037/tcr-2026-1534
UR  - https://doi.org/10.21037/tcr-2026-1534
ER  - 

APA

D, H., C, W., D, W., Y, D., & H, J. (2026). Genetic insights into lung squamous cell carcinoma: how TP53 and CSMD3 co-mutations shape prognosis and immune response.. Translational cancer research. https://doi.org/10.21037/tcr-2026-1534

Source records